Therapeutic Advances in Neurological Disorders

An update on best practice of deep brain stimulation in Parkinson’s disease

Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis

Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers

Embolic strokes of undetermined source: theoretical construct or useful clinical tool?

Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies

Progressive multiple sclerosis: latest therapeutic developments and future directions

Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Radiomics: a novel feature extraction method for brain neuron degeneration disease using 18F-FDG PET imaging and its implementation for Alzheimer’s disease and mild cognitive impairment

Advances in brain imaging in multiple sclerosis

Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age

Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson’s disease

Metabolic lipid muscle disorders: biomarkers and treatment

Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results

Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson’s disease: A pilot study

Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course

Therapeutic effect on experimental acute cerebral infarction is enhanced after nanoceria labeling of human umbilical cord mesenchymal stem cells

Levetiracetam and brivaracetam: a review of evidence from clinical trials and clinical experience

Human tissue kallikrein in the treatment of acute ischemic stroke

Multimodal MRI characteristics of the glioblastoma infiltration beyond contrast enhancement

Recent advances in treatment for narcolepsy

Relative health-related quality of life after treatment of unruptured intracranial aneurysms: long-term outcomes and influencing factors

Advances in imaging of brain abnormalities in neuromuscular disease

Comparing longitudinal brain atrophy measurement techniques in a real-world multiple sclerosis clinical practice cohort: towards clinical integration?

Whole-brain magnetic resonance imaging of plaque burden and lenticulostriate arteries in patients with different types of stroke

Severe rebound after cessation of fingolimod treated with ocrelizumab with coincidental transient aggravation: report of two cases

Parkinson’s-adapted cognitive stimulation therapy: a pilot randomized controlled clinical trial

Neuroimaging markers of clinical progression in chronic inflammatory demyelinating polyradiculoneuropathy

Stroke-related complications in large hemisphere infarction: incidence and influence on unfavorable outcome

Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational study

Does statin increase the risk of intracerebral hemorrhage in stroke survivors? A meta-analysis and trial sequential analysis

Autoimmune encephalitis associated with antibodies against the metabotropic glutamate receptor type 1: case report and review of the literature

The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®)

Clinical trials in multiple sclerosis: potential future trial designs

Hereditary defect of cobalamin metabolism with adolescence onset resembling multiple sclerosis: 41-year follow up in two cases

Structural brain signature of cognitive decline in Parkinson’s disease: DTI-based evidence from the LANDSCAPE study

Paradoxical association of symptomatic cerebral edema with local hypoperfusion caused by the ‘watershed shift’ after revascularization surgery for adult moyamoya disease: a case report

Endovascular equipoise shift in a phase III randomized clinical trial of sonothrombolysis for acute ischemic stroke

A new family with transportinopathy: increased clinical heterogeneity

Advances in cerebral amyloid angiopathy imaging

Are morphologic features of recent small subcortical infarcts related to specific etiologic aspects?

Repeated low-dose rituximab treatment based on the assessment of circulating B cells in patients with refractory myasthenia gravis

Preserved caudate function in young-onset patients with Parkinson’s disease: a dual-tracer PET imaging study

Immunology of stroke: from animal models to clinical trials

Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study

Structural brain network fingerprints of focal dystonia

Reply to: ‘Advances in imaging of brain abnormalities in neuromuscular disease’